CD4 and laryngotracheoesophageal cleft: Notably, recent research involving a group of LC patients, who were recruited before vaccination and displayed similar symptoms, identified two contrasting types of antiviral immune responses: one characterized by adequate antibody and CD4+ T cell responses and the other lacking these responses.